![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 29-Sep-2011[ | E-mail |
Share ] Contact: Jeanne Galatzer-Levy
jgala@uic.edu
312-996-1583
University of Illinois at Chicago
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
The protein, called PTK6, is found in normal skin and gut cells -- and in cancerous, but not normal, breast tissue.
"Our research has primarily focused on the normal function of this protein in the gut, where it regulates growth and differentiation," said Angela Tyner, professor of biochemistry and molecular genetics.
Epithelial cells, such as skin cells and the cells that line the colon, turn over rapidly. To replace them, new cells must be continuously produced that become specialized, or differentiated, to perform specific functions.
To further their investigation of PTK6, Tyner and her colleagues developed a mouse that lacked the PTK6 gene. Based on their observation of increased growth in the intestine, Tyner's group suspected that mice lacking PTK6 would be more susceptible to cancer.
Using a carcinogen, the researchers induced colon tumors resembling human sporadic colon cancer in mice lacking the PTK6 gene and in normal mice.
"Mice lacking PTK6 were highly resistant to the carcinogen and developed fewer tumors," Tyner said. "It was an unexpected result."
Tyner and her colleagues were able to establish the reason for this unexpected result. They found that PTK6 was activating a protein responsible for turning genes on and off called STAT3. Previous studies have established a role for STAT3 in proliferation and found that it plays an important role in many epithelial cancers, including skin cancer and colon cancer.
PTK6 seems to be playing opposite roles in normal and cancer cells, Tyner said.
"We believe that PTK6 may play a role in initiation of cancer in the colon, but we don't yet know what role PTK6 may play in metastasis."
Tyner's laboratory is continuing to investigate the role of PTK6 in cancer, which may provide a future target for therapies not only for colon cancer but breast cancer as well.
###
The study, published in Gastroenterology, was supported by the National Institutes of Health and the American Gastroenterological Association. Jessica Gierut was the study's first author, and Yu Zheng, Wenjun Bie, Robert Carroll, Susan Ball-Kell and Andrea Haegebarth also contributed to the study.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 29-Sep-2011[ | E-mail |
Share ] Contact: Jeanne Galatzer-Levy
jgala@uic.edu
312-996-1583
University of Illinois at Chicago
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
The protein, called PTK6, is found in normal skin and gut cells -- and in cancerous, but not normal, breast tissue.
"Our research has primarily focused on the normal function of this protein in the gut, where it regulates growth and differentiation," said Angela Tyner, professor of biochemistry and molecular genetics.
Epithelial cells, such as skin cells and the cells that line the colon, turn over rapidly. To replace them, new cells must be continuously produced that become specialized, or differentiated, to perform specific functions.
To further their investigation of PTK6, Tyner and her colleagues developed a mouse that lacked the PTK6 gene. Based on their observation of increased growth in the intestine, Tyner's group suspected that mice lacking PTK6 would be more susceptible to cancer.
Using a carcinogen, the researchers induced colon tumors resembling human sporadic colon cancer in mice lacking the PTK6 gene and in normal mice.
"Mice lacking PTK6 were highly resistant to the carcinogen and developed fewer tumors," Tyner said. "It was an unexpected result."
Tyner and her colleagues were able to establish the reason for this unexpected result. They found that PTK6 was activating a protein responsible for turning genes on and off called STAT3. Previous studies have established a role for STAT3 in proliferation and found that it plays an important role in many epithelial cancers, including skin cancer and colon cancer.
PTK6 seems to be playing opposite roles in normal and cancer cells, Tyner said.
"We believe that PTK6 may play a role in initiation of cancer in the colon, but we don't yet know what role PTK6 may play in metastasis."
Tyner's laboratory is continuing to investigate the role of PTK6 in cancer, which may provide a future target for therapies not only for colon cancer but breast cancer as well.
###
The study, published in Gastroenterology, was supported by the National Institutes of Health and the American Gastroenterological Association. Jessica Gierut was the study's first author, and Yu Zheng, Wenjun Bie, Robert Carroll, Susan Ball-Kell and Andrea Haegebarth also contributed to the study.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2011-09/uoia-kop092911.php
patrick swayze apartments apartments route 66 cindy crawford lynyrd skynyrd zach galifianakis
The experts from the health insurance industry stated that those who have been hit hard by the increasing costs of health care in the past years could be receiving some quantity of relief this 2012, especially mentioned to the employers of Connecticut.